Litcius/Paper detail

Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinoma

Meiying Song, Luoyang Wang, Suli Jiang, Jie Liang, Wěi Li, Wei Rao, Qiaochu Du, Guixian Liu, Haining Meng, Lei Tang, Zhifei Li, Yanyan Yang, Li Zhang, Bei Zhang, Bei Zhang

2024International Immunopharmacology14 citationsDOI

Topics & Concepts

ImmunotherapyHepatocellular carcinomaCancer researchCytotoxic T cellBlockadePD-L1Immune checkpointImmune systemCD8MedicineCombination therapyImmunologyLiver cancerTargeted therapyCancerBiologyInternal medicineReceptorBiochemistryIn vitroCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionPhagocytosis and Immune Regulation
Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinoma | Litcius